Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank74
3Y CAGR+21.0%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+21.0%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.17% |
| Q3 2025 | 7.91% |
| Q2 2025 | 7.03% |
| Q1 2025 | 3.87% |
| Q4 2024 | -0.49% |
| Q3 2024 | -0.57% |
| Q2 2024 | 0.21% |
| Q1 2024 | -1.95% |
| Q4 2023 | 8.04% |
| Q3 2023 | -1.96% |
| Q2 2023 | 5.28% |
| Q1 2023 | -1.73% |
| Q4 2022 | 2.92% |
| Q3 2022 | 148.21% |
| Q2 2022 | -7.35% |
| Q1 2022 | -10.37% |
| Q4 2021 | -13.94% |
| Q3 2021 | -9.92% |
| Q2 2021 | -12.73% |
| Q1 2021 | -13.48% |
| Q4 2020 | -15.68% |
| Q3 2020 | 25.70% |
| Q2 2020 | 16.22% |
| Q1 2020 | -9.41% |
| Q4 2019 | -10.61% |
| Q3 2019 | -9.06% |
| Q2 2019 | -14.70% |
| Q1 2019 | 2.76% |
| Q4 2018 | -12.93% |
| Q3 2018 | -64.51% |
| Q2 2018 | 326.22% |
| Q1 2018 | 258.35% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |